Several proteins, such as adhesion molecules, autoantibodies, chemokines, complement proteins, and cytokines, have been recognized as possible biomarkers of disease activity in cross-sectional studies of LN patients, but they have not been validated in larger cohorts. This evidence concerns the gene VTN and lobular neoplasia.